-
Instrumental Variable methods to target Hypothetical Estimands with longitudinal repeated measures data: Application to the STEP 1 trial
Authors:
Jack Bowden,
Jesper Madsen,
Bryan Goldman,
Aske Thorn Iversen,
Xiaoran Liang,
Stijn Vansteelandt
Abstract:
The STEP 1 randomized trial evaluated the effect of taking semaglutide vs placebo on body weight over a 68 week duration. As with any study evaluating an intervention delivered over a sustained period, non-adherence was observed. This was addressed in the original trial analysis within the Estimand Framework by viewing non-adherence as an intercurrent event. The primary analysis applied a treatmen…
▽ More
The STEP 1 randomized trial evaluated the effect of taking semaglutide vs placebo on body weight over a 68 week duration. As with any study evaluating an intervention delivered over a sustained period, non-adherence was observed. This was addressed in the original trial analysis within the Estimand Framework by viewing non-adherence as an intercurrent event. The primary analysis applied a treatment policy strategy which viewed it as an aspect of the treatment regimen, and thus made no adjustment for its presence. A supplementary analysis used a hypothetical strategy, targeting an estimand that would have been realised had all participants adhered, under the assumption that no post-baseline variables confounded adherence and change in body weight. In this paper we propose an alternative Instrumental Variable method to adjust for non-adherence which does not rely on the same `unconfoundedness' assumption and is less vulnerable to positivity violations (e.g., it can give valid results even under conditions where non-adherence is guaranteed). Unlike many previous Instrumental Variable approaches, it makes full use of the repeatedly measured outcome data, and allows for a time-varying effect of treatment adherence on a participant's weight. We show that it provides a natural vehicle for defining two distinct hypothetical estimands: the treatment effect if all participants would have adhered to semaglutide, and the treatment effect if all participants would have adhered to both semaglutide and placebo. When applied to the STEP 1 study, they both suggest a sustained, slowly decaying weight loss effect of semaglutide treatment.
△ Less
Submitted 3 July, 2024;
originally announced July 2024.
-
VARX Granger Analysis: Modeling, Inference, and Applications
Authors:
Lucas C. Parra,
Aimar Silvan Ortubay,
Maximilian Nentwich,
Jens Madsen,
Behtash Babadi
Abstract:
Complex systems, such as brains, markets, and societies, exhibit internal dynamics influenced by external factors. Disentangling delayed external effects from internal dynamics within these systems is often challenging. We propose using a Vector Autoregressive model with eXogenous input (VARX) to capture delayed interactions between internal and external variables. While this model aligns with Gra…
▽ More
Complex systems, such as brains, markets, and societies, exhibit internal dynamics influenced by external factors. Disentangling delayed external effects from internal dynamics within these systems is often challenging. We propose using a Vector Autoregressive model with eXogenous input (VARX) to capture delayed interactions between internal and external variables. While this model aligns with Granger's statistical formalism for testing "causal relations", the connection between the two is not widely understood. Here, we bridge this gap by providing fundamental equations, user-friendly code, and demonstrations using simulated and real-world data from neuroscience, physiology, sociology, and economics. Our examples illustrate how the model avoids spurious correlation by factoring out external influences from internal dynamics, leading to more parsimonious explanations of the systems. We also provide methods for enhancing model efficiency, such as L2 regularization for limited data and basis functions to cope with extended delays. Additionally, we analyze model performance under various scenarios where model assumptions are violated. MATLAB, Python, and R code are provided for easy adoption: https://github.com/lcparra/varx
△ Less
Submitted 30 June, 2024; v1 submitted 16 April, 2024;
originally announced April 2024.
-
Implementation and pratical aspects of quantitative decision-making in clinical drug development
Authors:
Juan J. Abellan,
Nicolas Bonnet,
Alex Carlton,
Paul Frewer,
Heiko Götte,
John-Philip Lawo,
Jesper Madsen,
Oliver Sailer,
Guido Thömmes,
Gaëlle Saint-Hilary
Abstract:
Quantitative decision-making (QDM) principles address the issues related to the map** of results to decisions, the synthesis of information and the quantification of uncertainty. Since the clinical drug development involves a succession of decisions to be made, QDM methods can be applied at various levels. At the study level, it can be used to properly design a study, and improve the decisions t…
▽ More
Quantitative decision-making (QDM) principles address the issues related to the map** of results to decisions, the synthesis of information and the quantification of uncertainty. Since the clinical drug development involves a succession of decisions to be made, QDM methods can be applied at various levels. At the study level, it can be used to properly design a study, and improve the decisions that are made either during the trial or at its end. Establishing decision criteria ahead of the study is essential here to address the need for speedy decisions, potentially in real time. At the project level, QDM can be used to inform decisions to continue, adapt or stop a drug development programme based on results from previous studies. At the portfolio level, QDM can be used to choose, prioritise and optimise the development portfolio, e.g. using the probability to reach market access or target sales within a predefined timeline. The increasing interest in QDM and its statistical nature led in 2017 to the development a cross-industry and academia Special Interest Group on QDM within the Society and the European Federation of Statisticians in the Pharmaceutical Industry (PSI and EFSPI). The activities of the group included discussing QDM examples, some published in the literature and some real anonymised ones covering several settings. While the methodologies, and to some extent the terminology, employed also varied depending on the context, discussions within the group distilled common principles to be considered when implementing QDM, particularly around the construction of QDM frameworks, assessment of operating characteristics and communication with the clinical team. The present manuscript presents those points to consider, ho** they can be helpful to statisticians interested in implementing QDM.
△ Less
Submitted 16 July, 2022;
originally announced July 2022.
-
Unbiased and Efficient Estimation of Causal Treatment Effects in Cross-over Trials
Authors:
Jeppe Ekstrand Halkjær Madsen,
Thomas Scheike,
Christian Pipper
Abstract:
We introduce causal inference reasoning to cross-over trials, with a focus on Thorough QT (TQT) studies. For such trials, we propose different sets of assumptions and consider their impact on the modelling strategy and estimation procedure. We show that unbiased estimates of a causal treatment effect are obtained by a G-computation approach in combination with weighted least squares predictions fr…
▽ More
We introduce causal inference reasoning to cross-over trials, with a focus on Thorough QT (TQT) studies. For such trials, we propose different sets of assumptions and consider their impact on the modelling strategy and estimation procedure. We show that unbiased estimates of a causal treatment effect are obtained by a G-computation approach in combination with weighted least squares predictions from a working regression model. Only a few natural requirements on the working regression and weighting matrix are needed for the result to hold. It follows that a large class of Gaussian linear mixed working models lead to unbiased estimates of a causal treatment effect, even if they do not capture the true data generating mechanism. We compare a range of working regression models in a simulation study where data are simulated from a complex data generating mechanism with input parameters estimated on a real TQT data set. In this setting, we find that for all practical purposes working models adjusting for baseline QTc measurements have comparable performance. Specifically, this is observed for working models that are by default too simplistic to capture the true data generating mechanism. Cross-over trials and particularly TQT studies can be analysed efficiently using simple working regression models without biasing the estimates for the causal parameters of interest.
△ Less
Submitted 30 May, 2022;
originally announced May 2022.
